[Survival rate of laryngeal cancer patients treated in Brazil's Unified Health System - SUS, 2002-2010].

IF 1.1 4区 医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Ciencia & saude coletiva Pub Date : 2024-09-01 Epub Date: 2023-08-30 DOI:10.1590/1413-81232024299.14342022
Tarssius Capelo Candido, Maria Teresa Bustamante Teixeira, Mário Círio Nogueira, Mariangela Leal Cherchiglia, Maximiliano Ribeiro Guerra
{"title":"[Survival rate of laryngeal cancer patients treated in Brazil's Unified Health System - SUS, 2002-2010].","authors":"Tarssius Capelo Candido, Maria Teresa Bustamante Teixeira, Mário Círio Nogueira, Mariangela Leal Cherchiglia, Maximiliano Ribeiro Guerra","doi":"10.1590/1413-81232024299.14342022","DOIUrl":null,"url":null,"abstract":"<p><p>The scope of this article was to analyze the five-year survival rate among patients with laryngeal cancer treated in the Unified Health System in Brazil and its regions between January 2002 and June 2010. There is still scarce information in Brazil regarding the scale and survival rate of laryngeal cancer patients, which makes it difficult to adopt specific strategies for the control of the condition in the country. A retrospective cohort study based on the National Oncology Database was conducted, and the survival probability rate for laryngeal cancer according to age, sex and Brazilian regions/states was estimated using the Kaplan-Meier method. The log-rank test was used to assess the differences observed, considering a 5% significance level. Survival in Brazil was estimated at 50.8% (95%CI: 49.9%-51.8%), being lower among male patients (49.1%; 95%CI: 48.10%-50.16%); between 50 and 60 years of age (48.4%; 95%CI: 46.7%-50.0%); for residents of the Northern region (45.5%; 95%CI: 39.5%-51.3%). The regional variation in the survival rate for laryngeal cancer in Brazil reveals disparities between Brazilian regions/states that may be linked to inequality of access to diagnosis and/or treatment.</p>","PeriodicalId":10195,"journal":{"name":"Ciencia & saude coletiva","volume":"29 9","pages":"e14342022"},"PeriodicalIF":1.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ciencia & saude coletiva","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1413-81232024299.14342022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

The scope of this article was to analyze the five-year survival rate among patients with laryngeal cancer treated in the Unified Health System in Brazil and its regions between January 2002 and June 2010. There is still scarce information in Brazil regarding the scale and survival rate of laryngeal cancer patients, which makes it difficult to adopt specific strategies for the control of the condition in the country. A retrospective cohort study based on the National Oncology Database was conducted, and the survival probability rate for laryngeal cancer according to age, sex and Brazilian regions/states was estimated using the Kaplan-Meier method. The log-rank test was used to assess the differences observed, considering a 5% significance level. Survival in Brazil was estimated at 50.8% (95%CI: 49.9%-51.8%), being lower among male patients (49.1%; 95%CI: 48.10%-50.16%); between 50 and 60 years of age (48.4%; 95%CI: 46.7%-50.0%); for residents of the Northern region (45.5%; 95%CI: 39.5%-51.3%). The regional variation in the survival rate for laryngeal cancer in Brazil reveals disparities between Brazilian regions/states that may be linked to inequality of access to diagnosis and/or treatment.

[2002-2010年在巴西统一卫生系统(SUS)接受治疗的喉癌患者的存活率]。
本文旨在分析2002年1月至2010年6月期间在巴西统一卫生系统及其地区接受治疗的喉癌患者的五年生存率。在巴西,有关喉癌患者的规模和生存率的信息仍然很少,因此很难在国内采取具体的策略来控制病情。该研究以国家肿瘤数据库为基础进行了一项回顾性队列研究,并使用卡普兰-梅耶法估算了根据年龄、性别和巴西地区/州划分的喉癌生存概率。采用对数秩检验评估观察到的差异,显著性水平为 5%。巴西的存活率估计为 50.8%(95%CI:49.9%-51.8%),男性患者(49.1%;95%CI:48.10%-50.16%)、50 至 60 岁患者(48.4%;95%CI:46.7%-50.0%)和北部地区居民(45.5%;95%CI:39.5%-51.3%)的存活率较低。巴西喉癌存活率的地区差异揭示了巴西地区/州之间的差距,这可能与诊断和/或治疗机会的不平等有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ciencia & saude coletiva
Ciencia & saude coletiva PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
3.60
自引率
11.80%
发文量
533
审稿时长
12 weeks
期刊介绍: Ciência & Saúde Coletiva publishes debates, analyses, and results of research on a Specific Theme considered current and relevant to the field of Collective Health. Its abbreviated title is Ciênc. saúde coletiva, which should be used in bibliographies, footnotes and bibliographical references and strips.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信